A Lymphocryptovirus is a genus of viruses within the subfamily Gammaherpesvirinae and family Herpesviridae. These viruses are characterized by their tropism for lymphocytes, particularly B lymphocytes, where they can establish both lytic and latent infections. The name "lymphocryptovirus" is derived from "lympho-" (referring to lymphocytes), "crypto-" (meaning hidden or latent, referring to their ability to establish latent infections), and "-virus."
Classification
- Group: dsDNA viruses (Baltimore Group I)
- Order: Herpesvirales
- Family: Herpesviridae
- Subfamily: Gammaherpesvirinae
- Genus: Lymphocryptovirus
Virology
Structure
Lymphocryptoviruses are enveloped viruses with an icosahedral capsid, typically 100-110 nm in diameter, surrounding a linear double-stranded DNA (dsDNA) genome. The entire virion, including the tegument and envelope, can be 150-200 nm in diameter.
Genome
The genome consists of a single molecule of linear dsDNA, ranging from approximately 170 to 184 kilobase pairs (kbp) in length. It contains both unique long and unique short regions, as well as repeat sequences. The genome encodes for numerous proteins involved in replication, immune evasion, and latency.
Replication Cycle
Lymphocryptoviruses exhibit a complex biphasic replication cycle:
- Lytic Infection: In permissive cells (e.g., some epithelial cells or activated B cells), the virus undergoes active replication, producing new virions. This phase involves immediate-early, early, and late gene expression, leading to viral DNA synthesis, capsid assembly, and budding from the host cell.
- Latency: This is a hallmark of lymphocryptoviruses, particularly in B lymphocytes. During latency, only a limited set of viral genes are expressed, allowing the virus to persist without causing cell lysis or an overt immune response. Latency can be reactivated under certain conditions (e.g., immunosuppression), leading to a lytic phase.
Tropism
The primary target cells for lymphocryptoviruses are B lymphocytes. The virus binds to specific receptors on the B-cell surface (e.g., CD21 for Epstein-Barr virus), allowing entry. They can also infect epithelial cells in some tissues.
Associated Diseases
Lymphocryptoviruses are significant human and animal pathogens, capable of causing a wide range of diseases, particularly those involving lymphoid tissues or due to immune dysregulation:
- Infectious Mononucleosis: In humans, the most common acute manifestation of infection with Human gammaherpesvirus 4 (Epstein-Barr virus) is infectious mononucleosis, characterized by fever, sore throat, swollen lymph nodes, and fatigue.
- Lymphoproliferative Disorders: Lymphocryptoviruses, especially Epstein-Barr virus, are strongly associated with various lymphoproliferative disorders, where infected B cells proliferate uncontrollably. These include:
- Burkitt's Lymphoma: An aggressive B-cell non-Hodgkin lymphoma, particularly prevalent in equatorial Africa.
- Hodgkin's Lymphoma: A type of lymphoma characterized by the presence of Reed-Sternberg cells.
- Post-transplant Lymphoproliferative Disorder (PTLD): Occurs in immunosuppressed organ transplant recipients, where EBV-infected B cells proliferate excessively due to impaired T-cell surveillance.
- Other B-cell Lymphomas: Including diffuse large B-cell lymphoma and T-cell lymphomas.
- Carcinomas: EBV is also linked to several epithelial cancers:
- Nasopharyngeal Carcinoma: A highly malignant tumor of the nasopharynx.
- Gastric Carcinoma: A significant proportion of gastric cancers show evidence of EBV infection.
Notable Species
The most well-known and extensively studied species in the genus Lymphocryptovirus is:
- Human gammaherpesvirus 4 (Epstein-Barr virus, EBV): The causative agent of infectious mononucleosis and is implicated in various cancers and autoimmune diseases.
Other lymphocryptoviruses infect other primate species, such as rhesus macaques and baboons, and are often studied as models for human disease.